Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://5k18a.pl
Are you over 18 and want to see adult content?
A complete backup of https://sofistik.com
Are you over 18 and want to see adult content?
A complete backup of https://hqseek.com
Are you over 18 and want to see adult content?
A complete backup of https://cambridgelive.org.uk
Are you over 18 and want to see adult content?
A complete backup of https://officialkdshoes.com
Are you over 18 and want to see adult content?
A complete backup of https://generaliceska.cz
Are you over 18 and want to see adult content?
A complete backup of https://westernpriorities.org
Are you over 18 and want to see adult content?
A complete backup of https://webalia.com
Are you over 18 and want to see adult content?
A complete backup of https://felix1.de
Are you over 18 and want to see adult content?
A complete backup of https://usa-co.com
Are you over 18 and want to see adult content?
A complete backup of https://faspe-ethics.org
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://eurotig.ro
Are you over 18 and want to see adult content?
A complete backup of https://dinanathshaw.com
Are you over 18 and want to see adult content?
A complete backup of https://smallsmaller.com
Are you over 18 and want to see adult content?
A complete backup of https://bezpieczny.pl
Are you over 18 and want to see adult content?
A complete backup of https://envoyer.io
Are you over 18 and want to see adult content?
A complete backup of https://maclarenart.com
Are you over 18 and want to see adult content?
A complete backup of https://nectome.com
Are you over 18 and want to see adult content?
A complete backup of https://dierspecialist.nl
Are you over 18 and want to see adult content?
A complete backup of https://kirksey.com
Are you over 18 and want to see adult content?
A complete backup of https://visitfrederick.org
Are you over 18 and want to see adult content?
A complete backup of https://revistaarcadia.com
Are you over 18 and want to see adult content?
Text
CMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included. CLINICAL VERSION: CANADIAN TIA SCORE Estimate 7-day Risk of Stroke or Carotid Revascularization. The Canadian Transient Ischaemic Score is decision tool stratifies patients’ seven day risk for stroke, with or without carotid endarterectomy/carotid artery stenting, after presenting to the emergency department with a transient ischemic attack. AR: QUANTIFICATION (VOLUMETRIC) Robert O Bonow, Blase A Carabello et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in Collaboration With the Society forBASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. CNS INTERNATIONAL PROGNOSTIC INDEX IN DIFFUSE LARGE B-CELL CNS recurrence/progression in patients with DLBCL can be devastating. Although some studies suggest a decline in the occurrence of CNS relapse in the rituximab era, certain high risk groups can still be identified and should be considered for CNS-directed trials or prophylactic therapies.MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS. NEWBORN HYPERBILIRUBINEMIA RATE OF RISE 60% of term infants and 80% of preterm newborns develop jaundice, a condition characterized by yellowing of the skin or whites of the eyes, arising from elevated serum bilirubin levels. MALT LYMPHOMA PROGNOSIS (MALT-IPI) Estimate prognosis in MALT lymphoma. The MALT-IPI prognostic index was developed using a database of patients treated in an international randomized trial IELSG-19 (n=401) treated with chlorambucil,rituximab, or both.
QXMD | MOVING RESEARCH INTO PRACTICE | QXMDREAD BY QXMDCALCULATE BY QXMDLEARN BY QXMDRESEARCH DISSEMINATIONINTERACTIVE TOOLS For Conference Organizers. Grow attendance for your next medical event or conference. No risk, no minimum commitment. Connect with a highly-engaged, almost 2-million strong community on the QxMD platform. Learn More. Decision Support Tools Available.CMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included. CLINICAL VERSION: CANADIAN TIA SCORE Estimate 7-day Risk of Stroke or Carotid Revascularization. The Canadian Transient Ischaemic Score is decision tool stratifies patients’ seven day risk for stroke, with or without carotid endarterectomy/carotid artery stenting, after presenting to the emergency department with a transient ischemic attack. AR: QUANTIFICATION (VOLUMETRIC) Robert O Bonow, Blase A Carabello et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in Collaboration With the Society forBASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. CNS INTERNATIONAL PROGNOSTIC INDEX IN DIFFUSE LARGE B-CELL CNS recurrence/progression in patients with DLBCL can be devastating. Although some studies suggest a decline in the occurrence of CNS relapse in the rituximab era, certain high risk groups can still be identified and should be considered for CNS-directed trials or prophylactic therapies.MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS. NEWBORN HYPERBILIRUBINEMIA RATE OF RISE 60% of term infants and 80% of preterm newborns develop jaundice, a condition characterized by yellowing of the skin or whites of the eyes, arising from elevated serum bilirubin levels. MALT LYMPHOMA PROGNOSIS (MALT-IPI) Estimate prognosis in MALT lymphoma. The MALT-IPI prognostic index was developed using a database of patients treated in an international randomized trial IELSG-19 (n=401) treated with chlorambucil,rituximab, or both.
QXMD | MOVING RESEARCH INTO PRACTICE | QXMD For Conference Organizers. Grow attendance for your next medical event or conference. No risk, no minimum commitment. Connect with a highly-engaged, almost 2-million strong community on the QxMD platform. Learn More. Decision Support Tools Available.FEATURED PAPERS
Read by QxMD helps you keep up-to-date with groundbreaking research in your area of practice. Leverage your existing university affiliation and subscription to get one-touch access to thousands of premium PDF articles from high-impact journals like the New England Journal of Medicine and the Lancet right on your iPad, iPhone, Android and web-enabled desktop. AR: QUANTIFICATION (VOLUMETRIC) Robert O Bonow, Blase A Carabello et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in Collaboration With the Society forCLL-IPI | QXMD
The CLL-IPI allows more individualized management of CLL patients in clinical practice (cf. The International CLL-IPI working group; The Lancet Oncology 2016). PULMONARY RESISTANCE TPR reflects the resistance to diastolic flow across the pulmonary circulation from PA to LV, neglecting LV diastolic pressure. TPR is easily influenced by alterations in LA pressure, and as such does not always reflect pulmonary vasculature. DIPSS PLUS SCORE FOR PROGNOSIS IN MYELOFIBROSIS The DIPSS was proposed and validated by Passamonti et al to estimate prognosis in myelofibrosis. The DIPSS plus score further refines the prior prognostic scoring system with the addition of DIPSS-independent risk factors, including karyotype, transfusion dependency and plateletcount.
DIALYSIS RISK AFTER CARDIAC SURGERY (CLEVELAND CLINIC Estimate risk of dialysis after cardiac surgery. This tool is adapted from the 2005 Thakar model (Cleveland Clinic Score) which is a clinical score to predict acute kidney injury after cardiac surgery by incorporating the effect of all of its major risk factors. ATOMIC SCALE SYMMETRY AND POLAR NANOCLUSTERS IN THE The nature of the "forbidden" local- and long-range polar order in nominally non-polar paraelectric phases of ferroelectric materials has been an open question since the discovery of ferroelectricity in oxide perovskites, ABO3 . A currently considered model suggests locally correlated displacements of B-site atoms along a subset of cubicdirections.
CHANGING THE CORTICAL CONDUCTOR'S TEMPO: NEUROMODULATION The claustrum is a thin sheet of neurons that is densely connected to many cortical regions and has been implicated in numerous high-order brain functions. Such brain functions arise from brain states that are influenced by neuromodulatory pathways from the cholinergic basal forebrain, dopaminergic substantia nigra and ventral tegmental area, and serotonergic raphe. BENCHMARKS FOR DETECTING 'BREAKTHROUGHS' IN CLINICAL OBJECTIVE: To understand how often 'breakthroughs,' that is, treatments that significantly improve health outcomes, can be developed. DESIGN: We applied weighted adaptive kernel density estimation to construct the probability density function for observed treatment effects from five publicly funded cohorts and one privately funded group. DATA SOURCES: 820 trials involving 1064 comparisons andCMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included.BASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. INTERNATIONAL IGAN PREDICTION TOOL Barbour SJ, Coppo R, Zhang H, et al. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. JAMA Internal Medicine 2019 July 1, 179 (7): 942-952MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS. MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. PRE-TEST PROBABILITY OF CAD (CAD CONSORTIUM) This calculator was developed and validated based on more than 5500 patients from 18 different hospitals across Europe and the United States (1), a collaborative effort of the CAD consortium.CMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included.BASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. INTERNATIONAL IGAN PREDICTION TOOL Barbour SJ, Coppo R, Zhang H, et al. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. JAMA Internal Medicine 2019 July 1, 179 (7): 942-952MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS. QXMD | MOVING RESEARCH INTO PRACTICE | QXMD For Conference Organizers. Grow attendance for your next medical event or conference. No risk, no minimum commitment. Connect with a highly-engaged, almost 2-million strong community on the QxMD platform. Learn More. Decision Support Tools Available.FEATURED PAPERS
Read by QxMD helps you keep up-to-date with groundbreaking research in your area of practice. Leverage your existing university affiliation and subscription to get one-touch access to thousands of premium PDF articles from high-impact journals like the New England Journal of Medicine and the Lancet right on your iPad, iPhone, Android and web-enabled desktop. PULMONARY RESISTANCE TPR reflects the resistance to diastolic flow across the pulmonary circulation from PA to LV, neglecting LV diastolic pressure. TPR is easily influenced by alterations in LA pressure, and as such does not always reflect pulmonary vasculature. FINDRISC DIABETES RISK CALCULATOR FINDRISC is a prediction tool to identify patients at risk of developing diabetes. It requires no laboratory testing and has been validated in multiple populations. MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. IMMUNE THROMBOCYTOPENIA AND COVID-19: CASE REPORT AND Immune thrombocytopenia, also known as immune thrombocytopenic purpura (ITP), has been reported as an important complication related to COVID-19.We present a 49-year-old male patient with systemic lupus erythematosus with lupus nephritis, antiphospholipid syndrome and history of ITP who developed an ITP flare in the context of COVID-19. He had no bleeding manifestations and had a good response CLINICAL VERSION: SPINAL INSTABILITY NEOPLASTIC SCORE The spinal instability neoplastic score (SINS) helps to assess tumor related instability of the vertebral column. It has been shown to useful in guiding the mobilization or operative management of patients with neoplastic spinal disease. DIALYSIS RISK AFTER CARDIAC SURGERY (CLEVELAND CLINIC Estimate risk of dialysis after cardiac surgery. This tool is adapted from the 2005 Thakar model (Cleveland Clinic Score) which is a clinical score to predict acute kidney injury after cardiac surgery by incorporating the effect of all of its major risk factors. CASE 16-2021: A 37-YEAR-OLD WOMAN WITH ABDOMINAL PAIN AND New England Journal of Medicine, Volume 384, Issue 21, Page 2054-2063,May 2021.
AUTOMATED CORONARY CALCIUM SCORING USING DEEP LEARNING Coronary artery disease (CAD), the most common manifestation of cardiovascular disease, remains the most common cause of mortality in the United States. Risk assessment is key for primary prevention of coronary events and coronary artery calcium (CAC) scoring using computed tomography (CT) is one such non-invasive tool. Despite the proven clinical value of CAC, the current clinical practiceCMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included.BASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. INTERNATIONAL IGAN PREDICTION TOOL Barbour SJ, Coppo R, Zhang H, et al. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. JAMA Internal Medicine 2019 July 1, 179 (7): 942-952MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS. MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. PRE-TEST PROBABILITY OF CAD (CAD CONSORTIUM) This calculator was developed and validated based on more than 5500 patients from 18 different hospitals across Europe and the United States (1), a collaborative effort of the CAD consortium.CMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included.BASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. INTERNATIONAL IGAN PREDICTION TOOL Barbour SJ, Coppo R, Zhang H, et al. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. JAMA Internal Medicine 2019 July 1, 179 (7): 942-952MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS. MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. PRE-TEST PROBABILITY OF CAD (CAD CONSORTIUM) This calculator was developed and validated based on more than 5500 patients from 18 different hospitals across Europe and the United States (1), a collaborative effort of the CAD consortium. QXMD | MOVING RESEARCH INTO PRACTICE | QXMD For Conference Organizers. Grow attendance for your next medical event or conference. No risk, no minimum commitment. Connect with a highly-engaged, almost 2-million strong community on the QxMD platform. Learn More. Decision Support Tools Available.FEATURED PAPERS
Read by QxMD helps you keep up-to-date with groundbreaking research in your area of practice. Leverage your existing university affiliation and subscription to get one-touch access to thousands of premium PDF articles from high-impact journals like the New England Journal of Medicine and the Lancet right on your iPad, iPhone, Android and web-enabled desktop. PULMONARY RESISTANCE TPR reflects the resistance to diastolic flow across the pulmonary circulation from PA to LV, neglecting LV diastolic pressure. TPR is easily influenced by alterations in LA pressure, and as such does not always reflect pulmonary vasculature. FINDRISC DIABETES RISK CALCULATOR FINDRISC is a prediction tool to identify patients at risk of developing diabetes. It requires no laboratory testing and has been validated in multiple populations. IMMUNE THROMBOCYTOPENIA AND COVID-19: CASE REPORT AND Immune thrombocytopenia, also known as immune thrombocytopenic purpura (ITP), has been reported as an important complication related to COVID-19.We present a 49-year-old male patient with systemic lupus erythematosus with lupus nephritis, antiphospholipid syndrome and history of ITP who developed an ITP flare in the context of COVID-19. He had no bleeding manifestations and had a good response MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. CLINICAL VERSION: SPINAL INSTABILITY NEOPLASTIC SCORE The spinal instability neoplastic score (SINS) helps to assess tumor related instability of the vertebral column. It has been shown to useful in guiding the mobilization or operative management of patients with neoplastic spinal disease. DIALYSIS RISK AFTER CARDIAC SURGERY (CLEVELAND CLINIC Estimate risk of dialysis after cardiac surgery. This tool is adapted from the 2005 Thakar model (Cleveland Clinic Score) which is a clinical score to predict acute kidney injury after cardiac surgery by incorporating the effect of all of its major risk factors. CASE 16-2021: A 37-YEAR-OLD WOMAN WITH ABDOMINAL PAIN AND New England Journal of Medicine, Volume 384, Issue 21, Page 2054-2063,May 2021.
AUTOMATED CORONARY CALCIUM SCORING USING DEEP LEARNING Coronary artery disease (CAD), the most common manifestation of cardiovascular disease, remains the most common cause of mortality in the United States. Risk assessment is key for primary prevention of coronary events and coronary artery calcium (CAC) scoring using computed tomography (CT) is one such non-invasive tool. Despite the proven clinical value of CAC, the current clinical practice QXMD | MOVING RESEARCH INTO PRACTICE | QXMDREAD BY QXMDCALCULATE BY QXMDLEARN BY QXMDRESEARCH DISSEMINATIONINTERACTIVE TOOLS For Conference Organizers. Grow attendance for your next medical event or conference. No risk, no minimum commitment. Connect with a highly-engaged, almost 2-million strong community on the QxMD platform. Learn More. Decision Support Tools Available.CMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included. CLINICAL VERSION: CANADIAN TIA SCORE Estimate 7-day Risk of Stroke or Carotid Revascularization. The Canadian Transient Ischaemic Score is decision tool stratifies patients’ seven day risk for stroke, with or without carotid endarterectomy/carotid artery stenting, after presenting to the emergency department with a transient ischemic attack.MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS.BASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. CLINICAL VERSION: SPINAL INSTABILITY NEOPLASTIC SCORE The spinal instability neoplastic score (SINS) helps to assess tumor related instability of the vertebral column. It has been shown to useful in guiding the mobilization or operative management of patients with neoplastic spinal disease. MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. CNS INTERNATIONAL PROGNOSTIC INDEX IN DIFFUSE LARGE B-CELL CNS recurrence/progression in patients with DLBCL can be devastating. Although some studies suggest a decline in the occurrence of CNS relapse in the rituximab era, certain high risk groups can still be identified and should be considered for CNS-directed trials or prophylactic therapies. GLOMERULOSCLEROSIS ON BIOPSY (2015) Differentiate glomerulosclerosis from kidney disease vs from aging. The glomerulosclerosis prediction tool was developed using the implantation biopsies of 1847 normotensive living kidney donors from Mayo Clinic (Minnesota and Arizona sites) and Cleveland Clinic. QXMD | MOVING RESEARCH INTO PRACTICE | QXMDREAD BY QXMDCALCULATE BY QXMDLEARN BY QXMDRESEARCH DISSEMINATIONINTERACTIVE TOOLS For Conference Organizers. Grow attendance for your next medical event or conference. No risk, no minimum commitment. Connect with a highly-engaged, almost 2-million strong community on the QxMD platform. Learn More. Decision Support Tools Available.CMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool.PHASES SCORE
The PHASES score is an aid for prediction of the risk of rupture for asymptomatic intracranial aneurysms. The score is based on a systematical review of six prospective cohort studies with subarachnoid hemorrhage as outcome. 8382 participants in the USA, Europe and Japan were included. CLINICAL VERSION: CANADIAN TIA SCORE Estimate 7-day Risk of Stroke or Carotid Revascularization. The Canadian Transient Ischaemic Score is decision tool stratifies patients’ seven day risk for stroke, with or without carotid endarterectomy/carotid artery stenting, after presenting to the emergency department with a transient ischemic attack.MGUS PROGNOSIS
Determine risk of malignant progression to myleoma or lymphoproliferative disorder. Patients with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of developing a hematologic malignancy, most often multiple myeloma from IgG and IgA MGUS, and other malignant lymphoproliferative disorders from IgM MGUS.BASDAI | QXMD
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity questionnaire contains six questions regarding subjective symptoms during the week prior to answering the questions. CLINICAL VERSION: SPINAL INSTABILITY NEOPLASTIC SCORE The spinal instability neoplastic score (SINS) helps to assess tumor related instability of the vertebral column. It has been shown to useful in guiding the mobilization or operative management of patients with neoplastic spinal disease. MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. CNS INTERNATIONAL PROGNOSTIC INDEX IN DIFFUSE LARGE B-CELL CNS recurrence/progression in patients with DLBCL can be devastating. Although some studies suggest a decline in the occurrence of CNS relapse in the rituximab era, certain high risk groups can still be identified and should be considered for CNS-directed trials or prophylactic therapies. GLOMERULOSCLEROSIS ON BIOPSY (2015) Differentiate glomerulosclerosis from kidney disease vs from aging. The glomerulosclerosis prediction tool was developed using the implantation biopsies of 1847 normotensive living kidney donors from Mayo Clinic (Minnesota and Arizona sites) and Cleveland Clinic.FEATURED PAPERS
Read by QxMD helps you keep up-to-date with groundbreaking research in your area of practice. Leverage your existing university affiliation and subscription to get one-touch access to thousands of premium PDF articles from high-impact journals like the New England Journal of Medicine and the Lancet right on your iPad, iPhone, Android and web-enabled desktop.READ BY QXMD
Read by QxMD helps you keep up-to-date with groundbreaking research in your area of practice. Leverage your existing university affiliation and subscription to get one-touch access to thousands of premium PDF articles from high-impact journals like the New England Journal of Medicine and the Lancet right on your iPad, iPhone, Android and web-enabled desktop.CMML CPSS-MOL
The CPSS-Mol is a new CMML-specific prognostic scoring system (CPSS) that incorporates molecular genetic data resulting in a 4-level integrated clinical/pathological/genetic risk stratification tool. STRUCTURAL DYNAMICS OF SARS-COV-2 VARIANTS: A HEALTH OBJECTIVES: The Covid-19 pandemic has been marked by sudden outbreaks of SARS-CoV-2 variants harboring mutations in both the N-terminal (NTD) and receptor binding (RBD) domains of the spike protein. The goal of this study was to predict the transmissibility of SARS-CoV-2 variants from genomic sequence data. METHODS: We used a target-based molecular modeling strategy combined with MULTIPLE MYELOMA PROGNOSIS (R-ISS) The Revised International Staging System (R-ISS) includes variables included in the original ISS (serum beta-2 microglobulin and serum albumin), while also including the additional prognostic information obtained from serum LDH and high-risk chromosomal abnormalities detected by interphase fluorescent in situ hybridization (iFISH) after CD138 plasma cell purification. PULMONARY RESISTANCE TPR reflects the resistance to diastolic flow across the pulmonary circulation from PA to LV, neglecting LV diastolic pressure. TPR is easily influenced by alterations in LA pressure, and as such does not always reflect pulmonary vasculature. PROGNOSIS IN HODGKIN'S DISEASE The Hasenclever International Prognostic Score (IPS) was designed to predict five-year freedom from progression of Hodgkin's disease. With each additional adverse prognostic factor, the predicted rate is reduced by approximately 8%. EXPECTED SPLEEN SIZE Spleen size is significantly influenced by body height and sex. This tool is designed to calculate approximate percentiles of an individual´s spleen size. NEWBORN HYPERBILIRUBINEMIA RATE OF RISE 60% of term infants and 80% of preterm newborns develop jaundice, a condition characterized by yellowing of the skin or whites of the eyes, arising from elevated serum bilirubin levels. EFFECTIVE DNA DAMAGE RESPONSE AFTER ACUTE BUT NOT CHRONIC Whether and how an acute immune challenge may affect DNA Damage Response (DDR) is unknown. By studying vaccinations against Influenza and SARS-CoV-2 (mRNA-based) we found acute increases of type-I interferon-inducible gene expression, oxidative stress and DNA damage accumulation in blood mononuclear cells of 9 healthy controls, coupled with effective anti-SARS-CoV-2 neutralizing antibody* Apps
* Read by QxMD
* Calculate by QxMD
* Learn by QxMD
* Solutions
* Research Dissemination* Interactive Tools
* Guideline Digitization * Conference Promotion * Services for Medical Journals * Read, Institutional Edition * Continuing Medical Education * Features for Developers* Contact
* General Enquiries
* Tech Support
* Corporate Sales
Select Page
* Apps
* Read by QxMD
* Calculate by QxMD
* Learn by QxMD
* Solutions
* Research Dissemination* Interactive Tools
* Guideline Digitization * Conference Promotion * Services for Medical Journals * Read, Institutional Edition * Continuing Medical Education * Features for Developers* Contact
* General Enquiries
* Tech Support
* Corporate Sales
BETTER DECISIONS AT THE POINT OF CARE Mobile solutions that drive evidence-based medicine in clinicalpractice.
Contact UsLearn More3
BETTER DECISIONS AT THE POINT OF CARE Mobile solutions that drive evidence-based medicine in clinicalpractice.
Contact Us
3
FOR HEALTHCARE PROFESSIONALS APPS TO KEEP UP WITH THE LATEST RESEARCH AND INTEGRATE DECISION SUPPORT TOOLS INTO PRACTICEREAD BY QXMD
READ BY QXMD HELPS YOU STAY ON TOP OF THE MOST IMPORTANT AND CUTTING-EDGE RESEARCHLearn More
CALCULATE BY QXMD
CALCULATE BY QXMD OFFERS >400 POINT-OF-CARE TOOLS TO EDUCATE AROUND PROGNOSIS, DIAGNOSIS AND OPTIMAL PATIENT MANAGEMENTLearn More
FOR ORGANIZATIONS
DISSEMINATE RESEARCH TO FRONT LINE CLINICIANS IN ORDER TO DRIVE PRACTICE CHANGE & IMPROVE HEALTHCARE QUALITY METRICS
TRY READ, INSTITUTIONAL EDITION TO MAXIMIZE VALUE FROM YOUR DIGITAL JOURNAL SUBSCRIPTIONS.
CONVERT MEDICAL EVIDENCE, GUIDELINES AND PROTOCOLS INTO PRACTICAL TOOLS YOUR CLINICIANS WILL LOVE TO USELearn More
Get Started Today
Learn More
DISSEMINATE RESEARCH TO FRONT LINE CLINICIANS IN ORDER TO DRIVE PRACTICE CHANGE & IMPROVE HEALTHCARE QUALITY METRICSLearn More
TRY READ, INSTITUTIONAL EDITION TO MAXIMIZE VALUE FROM YOUR DIGITAL JOURNAL SUBSCRIPTIONS.Get Started Today
CONVERT MEDICAL EVIDENCE, GUIDELINES AND PROTOCOLS INTO PRACTICAL TOOLS YOUR CLINICIANS WILL LOVE TO USELearn More
FOR RESEARCHERS
COLLABORATE WITH QXMD TO MAKE YOUR CLINICAL RESEARCH INSTANTLY AVAILABLE IN THE HANDS OF >1 MILLION PRACTICING HEALTHCARE PROVIDERSLearn More
FOR RESEARCHERS
COLLABORATE WITH QXMD TO MAKE YOUR CLINICAL RESEARCH INSTANTLY AVAILABLE IN THE HANDS OF >1 MILLION PRACTICING HEALTHCARE PROVIDERSLearn More
FOR GUIDELINE DEVELOPERS WE SOLVE KNOWLEDGE TRANSLATION BY ADAPTING YOUR WORK INTO AN INTERACTIVE DIGITAL TOOL AND DRIVING ENGAGEMENT WITH YOUR TARGETCLINICAL AUDIENCE.
Learn More
FOR MEDICAL & SCIENTIFIC JOURNALS*
INCREASE READERSHIP BY DISSEMINATING GUIDELINES & NEW RESEARCH TO YOURTARGET AUDIENCE.
*
ADAPT PROGNOSTIC MODELS INTO POINT OF CARE, DIGITAL DECISION SUPPORTTOOLS
*
HELP READERS ENGAGE WITH PUBLISHED CONTENTLearn More
FOR CONFERENCE ORGANIZERS*
GROW ATTENDANCE FOR YOUR NEXT MEDICAL EVENT OR CONFERENCE*
NO RISK, NO MINIMUM COMMITMENT*
CONNECT WITH A HIGHLY-ENGAGED, ALMOST 2-MILLION STRONG COMMUNITY ONTHE QXMD PLATFORM
Learn More
FOR CONFERENCE ORGANIZERS*
GROW ATTENDANCE FOR YOUR NEXT MEDICAL EVENT OR CONFERENCE*
NO RISK, NO MINIMUM COMMITMENT*
CONNECT WITH A HIGHLY-ENGAGED, ALMOST 2-MILLION STRONG COMMUNITY ONTHE QXMD PLATFORM
Learn More
DECISION SUPPORT TOOLS AVAILABLE MILLION RESEARCH CITATIONS READ MILLION QXMD USERS PER YEAR NUMBER OF PATIENTS WE NEED TO HELP TO MAKE IT ALL WORTH IT AT QXMD, WE WORK WITH RESEARCHERS, HOSPITALS, UNIVERSITIES, NON-PROFITS & OTHERS TO DISSEMINATE PUBLICATIONS & ADAPT CLINICAL RESEARCH INTO SIMPLE TO USE TOOLS. OUR GOAL IS ADOPTION OF PRACTICE CHANGING RESEARCH AT THE POINT OFCARE.
HOW CAN WE HELP YOU?Name
Email Address
Phone (optional)
Message
Get in Touch
OUR SOFTWARE
ABOUT READ
Read for iOS
Read for Android
Read for Web
Read for WordPress
ABOUT CALCULATE
Calculate for iOS
Calculate for AndroidCalculate for Web
ABOUT PEDI STAT
Pedi STAT for iOS
Pedi STAT for AndroidOUR SOLUTIONS
Research DisseminationInteractive Tools
Guideline Digitization Solutions for Medical Journals Conference Promotion Read, Institutional Edition Continuing Medical Education Features for DevelopersOUR COMPANY
Contact Us
Blog
Support
Cookie Policy
Privacy Policy
Terms of Use
Curator Program
Team
News
Allow All
MANAGE COOKIE PREFERENCESPERFORMANCE COOKIES
Always Active
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.FUNCTIONAL COOKIES
Always Active
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not functionproperly.
TARGETING COOKIES
Always Active
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.Confirm My Choices
Back Button
Back
PERFORMANCE COOKIES
Vendor Search Search Icon Filter IconClear Fliters
Information storage and accessApplyAll Consent Allowed
Select All Vendors
All Consent Allowed
*
33ACROSS
HOST DESCRIPTION
VIEW COOKIES
REPLACE-WITH-DYANMIC-HOST-ID*
Name
cookie name
Host
cookie host
Duration
cookie duration
Type
cookie type
Category
cookie category
Description
cookie category
*
33ACROSS
View Privacy Notice
3 Purposes
REPLACE-WITH-DYANMIC-VENDOR-IDArrow
Consent Purposes
Location Based Ads
Consent Allowed
Legitimate Interest PurposesPersonalize
Require Opt-Out
Features
Location Based Ads
Confirm My Choices
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0